title: [Toxoplasmosis in the heart transplant patient].
abstract: Toxoplasmosis is a well-known problem under immunosuppressive conditions in cardiac transplant patients. In our series 12% of the patients (8 of 65) had clinical and/or serological signs of active toxoplasmosis. Due to its serious prognosis once the clinical process has started we favor a generous diagnostic interpretation of the serological results and a broad indication to drug therapy.
authors.affiliation: Kardiologie und Herzgefasschirurgie, Universitätsspital Zürich.
authors.forename: M
authors.initials: M
authors.lastname: Waser
authors.forename: L
authors.initials: L
authors.lastname: Leonardi
authors.forename: P
authors.initials: P
authors.lastname: Mohacsi
authors.forename: A
authors.initials: A
authors.lastname: Laske
authors.forename: M
authors.initials: M
authors.lastname: Turina
authors.forename: A
authors.initials: A
authors.lastname: Gallino
mesh_terms: D000818:Animals; D002311:Cardiomyopathy, Dilated / Q000601:surgery*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D007074:Immunoglobulin G / Q000032:analysis; D009894:Opportunistic Infections / Q000276:immunology*; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000276:immunology*
chemical_list: D007074:Immunoglobulin G
vernacular_title: Die Toxoplasmose beim herztransplantierten Patienten.